News Minimalist logo

GLP-1 agonists like Ozempic lower cancer risks in study

ScienceAlert — July 8, 2024, 04:00 AM UTC

Summary: A study in JAMA suggests GLP-1 agonists, including Ozempic, reduce the risk of certain obesity-related cancers. Patients with Type 2 diabetes on these drugs had significantly lower risks of 10 out of 13 cancers studied. GLP-1 agonists like Ozempic may break the link between obesity and cancer. This could lead to more doctors prescribing these drugs over insulin for diabetes treatment.

Full article

Article metrics
Significance5.5
Scale & Impact0.0
Positivity8.0
Credibility7.8
What is this?

This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.

We analyze up to 10,000 news articles daily and find the most significant world news.

Read more about how we calculate significance, or see today's top rated news on the main page:

See today's news rankings

Timeline:

  1. [3.2]
    Weight loss drugs may enhance brain health in diabetes (Gizmodo)
    72d 19h
    Source
  2. [4.5]
    GLP-1 drugs offer benefits beyond obesity and diabetes (News-Medical.Net)
    73d 1h
    Source
  3. [3.3]
    Dr. Daniel Drucker discusses future of Ozempic-like drugs (New York Post )
    77d 17h
    Source
  4. [4.0]
    Semaglutide not linked to higher neuropsychiatric risks in T2DM (News-Medical.Net)
    79d 1h
    Source
  5. [2.7]
    Oral semaglutide matches DPP-4i in T2D adherence, persistence (News-Medical.Net)
    80d 8h
    Source
  6. [4.6]
    Ozempic linked to cognitive benefits in diabetes patients (PMLiVE)
    81d 0h
    Source
  7. [3.2]
    AI analysis of Reddit shows interest in GLP-1 drugs for weight loss and mental health benefits (News-Medical.Net)
    81d 10h
    Source
  8. [2.5]
    Semaglutide may pose risk of vision loss: Study urges caution (Business Standard)
    82d 7h
    Source
  9. [4.7]
    Ozempic improves heart and kidney health for diabetes patients (Sydney Morning Herald)
    83d 3h
    Source
  10. [4.9]
    Semaglutide (Ozempic) may reduce dementia risk and nicotine cravings (Neuroscience News)
    83d 15h
    Source
  11. [3.2]
    Ozempic linked to lower dementia risk, nicotine use - study (The Straits Times)
    83d 18h
    Source
  12. [3.2]
    Ozempic linked to lower dementia risk, nicotine use in study (The Globe and Mail)
    83d 18h
    Source
  13. [3.9]
    Antidiabetic drugs linked to lower dementia risk in T2DM (News-Medical.Net)
    83d 19h
    Source
  14. [4.0]
    Ozempic linked to lower dementia rate in Oxford study (BNN Bloomberg)
    84d 3h
    Source
  15. [3.5]
    Ozempic and similar drugs may lower cancer risks (Forbes Australia)
    84d 8h
    Source
  16. [3.3]
    GLP-1 agonists lower dementia risk for diabetes patients (PsyPost)
    84d 11h
    Source
  17. [3.9]
    Weight-loss jabs lower cancer risk compared to insulin - study (The Conversation)
    84d 20h
    Source
  18. [4.7]
    GLP-1 agonists reduce cancer risk in type 2 diabetes (Inside Precision Medicine)
    85d 20h
    Source
  19. [3.4]
    GLP-1s reduce cancer risk in type 2 diabetes patients (PMLiVE)
    86d 0h
    Source
  20. [3.9]
    GLP-1 drugs linked to lower cancer risks in diabetes patients (Ars Technica)
    86d 20h
    Source
  21. [3.5]
    Semaglutide linked to rare eye disease causing vision loss (ScienceAlert)
    87d 1h
    Source
  22. [2.2]
    Semaglutide linked to higher risk of NAION in study (The Express Tribune)
    87d 23h
    Source
  23. [2.5]
    Semaglutide (Ozempic) linked to increased risk of blindness (Insight)
    88d 8h
    Source
  24. [5.3]
    GLP-1 meds like Ozempic, Wegovy may lower cancer risk (CTV News)
    88d 22h

    ScoresSource
  25. [4.4]
    GLP-1 diabetes drugs reduce cancer risk, study finds (The Manila Times)
    89d 20h
    Source
  26. [5.0]
    GLP-1 medications may lower risk of certain cancers (CNN)
    90d 11h

    ScoresSource
  27. [2.2]
    GLP-1s lower risk of 10 obesity-related cancers in diabetes (Medpage Today)
    90d 15h
    Source
  28. [5.2]
    GLP-1 drugs like Ozempic may reduce cancer risk (Quartz)
    90d 16h

    ScoresSource
  29. [5.1]
    GLP-1 treatments reduce cancer risk in diabetes patients (GMA News Online)
    90d 17h

    ScoresSource
  30. [5.1]
    GLP-1 drugs reduce cancer risks for diabetes patients (Finimize)
    90d 20h

    ScoresSource
  31. [1.3]
    Weight loss drugs linked to rare eye condition risk (India TV News)
    91d 8h
    Source
  32. [2.9]
    Weight-loss drugs may increase risk of rare blindness (Firstpost)
    92d 0h
    Source
  33. [3.2]
    Novo Nordisk weight loss drugs linked to rare eye condition (CNBC)
    92d 2h
    Source
  34. [3.3]
    Ozempic linked to rare blindness cases in study (Business Insider)
    92d 18h
    Source
  35. [3.2]
    Wegovy, Ozempic linked to sight-threatening eye disorder in study (GMA News Online)
    92d 20h
    Source
  36. [3.4]
    Weight loss and diabetes drugs linked to rare blindness risk (CNN)
    92d 21h
    Source
  37. [3.2]
    Weight-loss jabs linked to potential blindness risk in study (The Guardian)
    92d 21h
    Source